RÉFÉRENCES

Histoire du Cannabis & Informations générales

Bridgeman, Mary Barna, and Daniel T Abazia. “Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.” P & T : a peer-reviewed journal for formulary management vol. 42,3 (2017): 180-188. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/

Conrad, Chris. Hemp for health: The medicinal and nutritional uses of Cannabis sativa. Inner Traditions/Bear & Co, 1997.

Mechoulam, Raphael. "The pharmacohistory of Cannabis sativa." Cannabinoids as therapeutic agents (1986): 1-19.

Butrica, James L. "The medical use of cannabis among the Greeks and Romans." Journal of Cannabis Therapeutics 2.2 (2002): 51-70.

https://www.tandfonline.com/doi/abs/10.1300/J175v02n02_04

Lu, Xiaozhai, and Robert C. Clarke. "The cultivation and use of hemp (Cannabis sativa L.) in ancient China." Journal of the International Hemp Association 2.1 (1995): 26-30.

https://valapi.ga/full_825.pdf

Touw, Mia. "The religious and medicinal uses of Cannabis in China, India and Tibet." Journal of psychoactive drugs 13.1 (1981): 23-34.

https://www.tandfonline.com/doi/abs/10.1080/02791072.1981.10471447

Turner, Carlton E., Mahmoud A. Elsohly, and Edward G. Boeren. "Constituents of Cannabis sativa L. XVII. A review of the natural constituents." Journal of Natural Products 43.2 (1980): 169-234.

https://pubs.acs.org/doi/pdf/10.1021/np50008a001

Zuardi, Antonio Waldo, et al. "Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug." Brazilian journal of medical and biological research 39.4 (2006): 421-429.

http://www.scielo.br/scielo.php?pid=s0100-879x2006000400001&script=sci_arttext

Zhornitsky, Simon, and Stéphane Potvin. "Cannabidiol in humans—the quest for therapeutic targets." Pharmaceuticals 5.5 (2012): 529-552.

https://www.mdpi.com/1424-8247/5/5/529/htm

Russo, Ethan B. "Cannabidiol claims and misconceptions." Trends in pharmacological sciences 38.3 (2017): 198-201.

https://reader.elsevier.com/reader/sd/pii/S0165614716301869?token=91E93FBA6CFD1BE2C4AD68498F3BD831DE3269217C8723E4C8BBB0B549A7F5EE483BEA2CE0841FDD2C228F98BBBB6922 OU https://www.sciencedirect.com/science/article/abs/pii/S0165614716301869

Acne

Oláh, Attila et al. “Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.” The Journal of clinical investigation vol. 124,9 (2014): 3713-24. doi:10.1172/JCI64628

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151231/?report=reader

Douleurs, Inflammation & Médecine alternative

Xiong, Wei et al. “Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.” The Journal of experimental medicine vol. 209,6 (2012): 1121-34. doi:10.1084/jem.20120242
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/ 

Booz, George W. “Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.” Free radical biology & medicine vol. 51,5 (2011): 1054-61. doi:10.1016/j.freeradbiomed.2011.01.007

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/

Lynch, Mary, and Melanie KELLY. "Use of cannabinoids in the treatment of ocular inflammation and/or pain." https://www.lens.org/lens/patent/159-591-346-889-163/fulltext

Alison Ribeiro et al. “Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor.” European Journal of Pharmacology, Volume 678, Issues 1–3, 2012,

(http://www.sciencedirect.com/science/article/pii/S0014299912000052)

Hurd, Yasmin L. "Cannabidiol: swinging the marijuana pendulum from ‘weed’to medication to treat the opioid epidemic." Trends in Neurosciences 40.3 (2017): 124-127.

https://reader.elsevier.com/reader/sd/pii/S0166223617300012?token=3947D1A9B9D70E4E1D4DEF73D63D12D06ECC92758DE7F667D28CE8343DA8C99C89F4889E41BE38599C326502340992E8 OU  https://www.sciencedirect.com/science/article/abs/pii/S0166223617300012

Burstein, Sumner. "Cannabidiol (CBD) and its analogs: a review of their effects on inflammation." Bioorganic & medicinal chemistry 23.7 (2015): 1377-1385.

https://reader.elsevier.com/reader/sd/pii/S0968089615000838?token=E35BDE63513C252FE9B89D319054FFC16B04849D9B2CA53C95D6BAE3FE79D830CFB9DF9AD962CA2746A7C249E4663CCA

Stress, Anxiété & Sommeil

Blessing, Esther M et al. “Cannabidiol as a Potential Treatment for Anxiety Disorders.” Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics vol. 12,4 (2015): 825-36. doi:10.1007/s13311-015-0387-1
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604171/ 

Shannon, Scott, and Janet Opila-Lehman. “Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.” The Permanente journal vol. 20,4 (2016): 16-005. doi:10.7812/TPP/16-005

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/

Bergamaschi, Mateus M et al. “Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.” Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 36,6 (2011): 1219-26. doi:10.1038/npp.2011.6

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/

Babson, Kimberly A., James Sottile, and Danielle Morabito. "Cannabis, cannabinoids, and sleep: a review of the literature." Current psychiatry reports 19.4 (2017): 23.
 https://www.med.upenn.edu/cbti/assets/user-content/documents/s11920-017-0775-9.pdf 

Carlini, Elisaldo A., and Jomar M. Cunha. "Hypnotic and antiepileptic effects of cannabidiol." The Journal of Clinical Pharmacology 21.S1 (1981): 417S-427S.

https://www.ncbi.nlm.nih.gov/pubmed/7028792?dopt=Abstract

Shannon, Scott et al. “Cannabidiol in Anxiety and Sleep: A Large Case Series.” The Permanente journal vol. 23 (2019): 18-041. doi:10.7812/TPP/18-041

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/

Linge R, Jiménez-Sánchez L, Campa L, Pilar-Cuéllar F, Vidal R, Pazos A, Adell A, Díaz Á. “Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.” Neuropharmacology. 2016 Apr;103:16-26. doi: 10.1016/j.neuropharm.2015.12.017. Epub 2015 Dec 19.

https://www.ncbi.nlm.nih.gov/pubmed/26711860

Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, Santos Filho A, Freitas-Ferrari MC, McGuire PK, Zuardi AW, Busatto GF, Hallak JE. “Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.” J Psychopharmacol. 2011 Jan;25(1):121-30. doi: 10.1177/0269881110379283. Epub 2010 Sep 9.

https://www.ncbi.nlm.nih.gov/pubmed/20829306

CBD, THC and other Cannabinoides

Ashton, C. H. "Biomedical benefits of cannabinoids?." Addiction biology 4.2 (1999): 111-126.

https://onlinelibrary.wiley.com/doi/abs/10.1080/13556219971623

Mechoulam R, Parker LA, Gallily R.  “Cannabidiol: an overview of some pharmacological aspects.“ J Clin Pharmacol. 2002 Nov;42(S1):11S-19S.

https://www.ncbi.nlm.nih.gov/pubmed/12412831